MENLO PARK, Calif. and MADISON, Wis., May 18, 2021 /PRNewswire/ -- Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced that it has agreed to make a ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Madison-based Mirus Bio, a manufacturer of transfection ...
In scientific terms, transfection represents a type of macromolecule delivery in which large, negatively charged polymers (DNA, RNA) are delivered through cellular membranes and into the intracellular ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced the signing of a definitive agreement to acquire Mirus Bio for $600 million. This deal is ...
MADISON, Wis., Aug. 11, 2021 /PRNewswire/ -- Mirus Bio, an innovator in transfection technologies, today announces the launch of the TransIT® VirusGEN® GMP product line. This expansion to the existing ...
MilliporeSigma, the North American life sciences business of the German company Merck KGaA, has agreed to acquire Mirus Bio for $600 million. Spun off from the University of Wisconsin in 1995, the ...
MADISON, Wis., Aug. 3, 2023 /PRNewswire/ -- Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to support cell and gene therapy production, biopharmaceutical ...
BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the signing of a definitive agreement to acquire Mirus ...
-- Lipid-polymer nanocomplexes (LPNCs) developed by Mirus enable superior transfection performance in a range of delivery applications -- Investment will support GMP launch of TransIT VirusGEN for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback